Health

The alarming surge of cardiomyopathy-associated hospital admissions among methamphetamine users in the American West has raised significant concerns. According to a recent study based on data from the National Inpatient Sample (NIS), methamphetamine-related cardiomyopathy admissions have increased by a staggering 231% from 2008 to 2020 nationwide. This spike is in stark contrast to the mere
0 Comments
ADHD, or attention-deficit/hyperactivity disorder, is a common neurodevelopmental disorder that affects both children and adults. In a recent observational study conducted in Sweden, researchers found that starting medication for ADHD was linked to a lower risk of death, particularly from “unnatural” causes such as unintentional injuries, suicide, and accidental poisonings. This study sheds light on
0 Comments
Amyotrophic lateral sclerosis (ALS) stripped Grace Armant of her ability to speak, leaving her reliant on a machine to help her breathe, yet UnitedHealthcare repeatedly denied coverage for this crucial medical equipment. Unfortunately, Armant is not alone in facing these challenges. Doctors across the country report that insurers like UnitedHealthcare have made it increasingly difficult
0 Comments
UnitedHealth Group (UHG) has emerged as a dominant force in the healthcare industry, with nearly $400 billion in revenue and $22.4 billion in profits in 2023 alone. This financial success has been achieved through vertical integration, allowing UHG to control everything from health insurance to pharmaceuticals. This level of control raises concerns about the impact
0 Comments
Amblyopia, commonly referred to as “lazy eye,” has been linked to an increased risk of cardiometabolic disorders in adulthood, according to a recent observational cohort study conducted by researchers at University College London’s (UCL) Great Ormond Street Institute of Child Health. The study, which involved individuals over the age of 40 living with amblyopia, revealed
0 Comments
A recent Phase II randomized controlled trial has shown promising results for a novel fixed-dose combination of alpibectir-ethionamide in patients with tuberculosis (TB). The trial demonstrated similar levels of bactericidal activity to isoniazid, a commonly used anti-TB drug, with no serious adverse events and good tolerability. It is essential to find new treatment options for
0 Comments
The integration of artificial intelligence (AI) into healthcare settings, specifically in clinician-patient conversations, raises serious concerns regarding security and privacy issues. While AI has the potential to streamline processes and improve patient care, the lack of clarity surrounding data protection and confidentiality is a significant barrier to its widespread adoption. The announcement of a new
0 Comments